Status:
COMPLETED
Serotonin, Impulsivity, and Cocaine Dependence Treatment
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine Dependence
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.
Detailed Description
Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopra...
Eligibility Criteria
Inclusion
- male and female subjects age 18 to 50 who currently meet DSM-IV criteria for cocaine dependence.
- female subjects: a negative pregnancy test
Exclusion
- current or past DSM-IV Axis I disorder other than substance abuse/dependence
- any serious non-psychiatric medical illness requiring ongoing medical treatment
- substance dependence other than cocaine within the last 3 months
- negative urine drug screen for cocaine at time of testing
- for female subjects: a positive pregnancy test
Key Trial Info
Start Date :
April 1 2001
Trial Type :
INTERVENTIONAL
End Date :
November 1 2004
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00297505
Start Date
April 1 2001
End Date
November 1 2004
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas - Houston Health Science Center
Houston, Texas, United States, 77030